[HTML][HTML] The use of systemic corticosteroids in asthma management in Latin American countries
The stepwise treatment approach recommended by the Global Initiative for Asthma (GINA)
includes systemic corticosteroids (SCS) suggested as a final step if asthma is severe and/or …
includes systemic corticosteroids (SCS) suggested as a final step if asthma is severe and/or …
It is time to end our love affair with short-acting β2-agonists in asthma
MG Crooks, S Faruqi - ERJ Open Research, 2022 - Eur Respiratory Soc
It is time to end our love affair with short-acting β2-agonists in asthma | European
Respiratory Society Skip to main content Main menu Home Current issue Early View …
Respiratory Society Skip to main content Main menu Home Current issue Early View …
[HTML][HTML] Overprescription of short-acting β2 agonists: reflections from the SABINA study in Brazil
MA Antila, A Souza-Machado, MG Gregório… - Jornal Brasileiro de …, 2024 - SciELO Brasil
Objective: To assess prescription patterns for short-acting b2 agonists (SABAs) and other
asthma medications in asthma patients treated by specialists and participating in the SABA …
asthma medications in asthma patients treated by specialists and participating in the SABA …
[HTML][HTML] GEMA 5.3. Spanish guideline on the management of asthma
VP Moral, I Alobid, CÁ Rodríguez, MB Aparicio… - Open Respiratory …, 2023 - Elsevier
Abstract The Spanish Guideline on the Management of Asthma, better known by its acronym
in Spanish GEMA, has been available for more than 20 years. Twenty-one scientific …
in Spanish GEMA, has been available for more than 20 years. Twenty-one scientific …
Prescrição excessiva de β2-agonistas de curta duração: reflexões a partir do estudo SABINA no Brasil
MA Antila, A Souza-Machado, MG Gregório… - Jornal Brasileiro de …, 2024 - SciELO Brasil
Objetivo: Avaliar os padrões de prescrição de short-acting β2 agonists (SABAs, β2-
agonistas de curta duração) e outros medicamentos para asma em pacientes tratados por …
agonistas de curta duração) e outros medicamentos para asma em pacientes tratados por …
[HTML][HTML] Consultas a urgencia y valores espirométricos tras el reemplazo de salmeterol/fluticasona por budesonida/formoterol en pacientes con asma moderada a …
B San MartÍn, V Reveco - Revista chilena de enfermedades …, 2023 - SciELO Chile
El asma se caracteriza por su impacto deletéreo que incluye gran coste económico para el
sistema de salud. En pacientes con asma mal controlada a pesar del tratamiento, se …
sistema de salud. En pacientes con asma mal controlada a pesar del tratamiento, se …
[HTML][HTML] How to implement the anti-inflammatory reliever treatment proposed by the Global Initiative for Asthma in low-and middle-income countries
CA Torres-Duque, I Perna-Reyes… - Exploration of Asthma …, 2024 - explorationpub.com
There are no plausible arguments to consider that the best evidence-based asthma
treatment should be different in low-and middle-income countries (LMICs). A few decades …
treatment should be different in low-and middle-income countries (LMICs). A few decades …
Beware SABA Overuse: a Message from the Global SABINA Program
A Michaud, P Hernandez, ED Penz… - Current Treatment Options …, 2023 - Springer
Purpose of review The goal of this paper is to highlight the design and outcomes of the
SABa use IN Asthma (SABINA) research program. The SABINA program was designed to …
SABa use IN Asthma (SABINA) research program. The SABINA program was designed to …
[PDF][PDF] СВІТОВІ ТЕНДЕНЦІЇ ТЕРАПІЇ ПАЦІЄНТІВ З БРОНХІАЛЬНОЮ АСТМОЮ-ПЕРСОНІФІКОВАНИЙ ПІДХІД ДО ЛІКУВАННЯ
Бронхіальна астма (БА) відноситься до тих захворювань, які суттєво порушують
адаптацію пацієнтів у суспільстві та родині, призводять до тимчасової та стійкої втрати …
адаптацію пацієнтів у суспільстві та родині, призводять до тимчасової та стійкої втрати …